Introduced
by
To prohibit retail “point of purchase” displays for over-the-counter medicines containing just pseudoephedrine or ephedrine. These products could only be kept behind the counter. Merchants would be required to see a buyer’s photo identification before selling them, and require buyers to sign a log indicating how much was purchased.
Referred to the Committee on Health Policy
Reported without amendment
With the recommendation that the bill be referred to the Committee on Judiciary.
Referred to the Committee on Judiciary
Reported without amendment
With the recommendation that the substitute (H-1) be adopted and that the bill then pass.
Substitute offered
To replace the previous version of the bill with one adopts the provisions contained in the Senate-passed version of Senate Bill 189 and splits them between the two bills, clarifies the three ways retailers can maintain ephedrine and pseudoephedrine products, requires stores to display point of purchase warning signs, and does not invalidate current local ordinances related to this issue, but prohibits new ones.
The substitute passed by voice vote
Amendment offered
by
To require the proposed point of purchase warning signs to be available on the Department of Community Health's web site.
The amendment passed by voice vote
Amendment offered
by
To change the age below which a person would be prohibited from purchasing ephedrine or pseudoephedrine from 18 to 17.
The amendment passed 50 to 56 (details)
Passed in the House 104 to 5 (details)
To restrict retail “point of purchase” displays for over-the-counter medicines containing just pseudoephedrine or ephedrine, and ban their sale to a person under 18 years old. Merchants would be required to see a buyer’s photo identification before selling these products. Unless the products were kept behind the counter or in a locked case, merchants would be required to maintain video surveillance and/or attach antitheft devices to each package, and to maintain a log detailing the quantity and purchaser for each sale. These provisions are divided between this and Senate Bill 189.
Referred to the Committee on Health Policy
Reported without amendment
With the recommendation that the bill pass.
Passed in the Senate 35 to 0 (details)
To restrict retail “point of purchase” displays for over-the-counter medicines containing just pseudoephedrine or ephedrine, and ban their sale to a person under 18 years old. Merchants would be required to see a buyer’s photo identification before selling these products. Unless the products were kept behind the counter or in a locked case, merchants would be required to maintain video surveillance and/or attach antitheft devices to each package, and to maintain a log detailing the quantity and purchaser for each sale. These provisions are divided between this and Senate Bill 189.
